UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2020 2021-01-05 Future report Set alerts
Q1 2020 2020-10-01 Future report Set alerts
Q4 2019 2020-07-16 -0.06 -4.10
Q3 2019 2020-04-07 0.01 -0.15
Q2 2019 2020-01-07 0.06 -0.07
Q1 2019 2019-10-03 0.08 -0.03
Q4 2018 2019-07-10 0.25 0.07
Q3 2018 2019-04-02 0.19 -0.12
Q2 2018 2019-01-04 0.22 -0.10
Q1 2018 2018-09-27 0.16 -0.15

Ratings

2016-04-08 Lower Price Target KeyBanc Overweight $17.00 to $16.00
2016-04-08 Initiated Coverage Piper Jaffray Neutral $12.00
2016-04-08 Lower Price Target KeyCorp Overweight $17.00 to $16.00
2016-04-08 Initiated Coverage Piper Jaffray Cos. Neutral $12.00
2016-04-05 Downgrade Canaccord Genuity Buy to Hold $14.50 to $13.00
2016-01-08 Reiterated Rating Canaccord Genuity Buy $17.50 to $14.50
2016-01-08 Reiterated Rating Piper Jaffray Neutral $14.00 to $12.00
2015-11-10 Downgrade Raymond James Outperform to Market Perform
2015-11-10 Downgrade Raymond James Financial Inc. Outperform to Market Perform
2015-10-09 Reiterated Rating Piper Jaffray Hold $18.00 to $14.00
2015-10-09 Lower Price Target Raymond James Outperform $18.00 to $15.00
2015-10-09 Reiterated Rating Canaccord Genuity Buy $19.00 to $17.50
2015-09-23 Initiated Coverage Sidoti Neutral $14.50
2015-07-23 Initiated Coverage KeyBanc Overweight $20.00
2015-07-18 Lower Price Target Raymond James Outperform $20.00 to $18.00
2015-07-17 Reiterated Rating Canaccord Genuity Buy $19.00
2015-04-10 Reiterated Rating Canaccord Genuity Buy $20.00
2015-01-29 Reiterated Rating Canaccord Genuity Buy $22.00
2015-01-11 Reiterated Rating Canaccord Genuity Buy $22.00
2015-01-09 Boost Price Target Piper Jaffray Overweight $17.00 to $21.00
2014-07-24 Reiterated Rating Raymond James Outperform $18.00 to $17.00
2014-06-19 Upgrade Canaccord Genuity Hold to Buy $16.25 to $20.00
2014-05-16 Lower Price Target Raymond James $19.00 to $18.00
2014-04-10 Boost Price Target Canaccord Genuity $15.50 to $16.25
2014-03-12 Upgrade Raymond James Market Perform to Outperform $19.00
2013-10-11 Boost Price Target Canaccord Genuity Hold $11.50 to $13.00
2012-10-09 Reiterated Canaccord Genuity Hold $14 to $13.50
2011-07-15 Upgrade Canaccord Genuity Hold to Buy $15 to $16.50
2011-06-14 Downgrade Wedbush Neutral to Underperform $14 to $12
2009-09-04 Reiterated Caris & Company Above Average $13 to $15
2009-07-17 Reiterated Caris & Company Above Average $15 to $13
2009-01-07 Downgrade Caris & Company Buy to Above Average $20 to $15
2008-09-26 Initiated Caris & Company Buy $20
2008-04-11 Reiterated Friedman Billings Mkt Perform $14 to $16
2008-04-03 Reiterated Friedman Billings Mkt Perform $16 to $14
2007-09-13 Reiterated Canaccord Adams Buy $23 to $25
2007-04-23 Upgrade Sun Trust Rbsn Humphrey Neutral to Buy $20
2016-04-08 Lower Price Target KeyBanc Overweight $17.00 to $16.00
2016-04-08 Initiated Coverage Piper Jaffray Neutral $12.00
2016-04-08 Lower Price Target KeyCorp Overweight $17.00 to $16.00
2016-04-08 Initiated Coverage Piper Jaffray Cos. Neutral $12.00
2016-04-05 Downgrade Canaccord Genuity Buy to Hold $14.50 to $13.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Avista Capital Partners GP, LLC 1.08%  (381406) ANGO / LNTH /
Burgstahler David F 1.08%  (381406) ANGO / INCR / LNTH /
DEVIVO JOSEPH President and CEO 0.56%  (198451) ANGO /
Clemmer James C President and CEO 0.32%  (111817) ANGO / COV / LNTH /
BUCCI VINCENT 0.25%  (88312) ANGO /
Meteny Dennis S 0.20%  (70248) ANGO /
GOLD JEFFREY 0.17%  (61134) ANGO /
DONNELLY HOWARD W 0.17%  (58703) ANGO /
Gould Kevin J 0.14%  (48817) ANGO /
JOHNSON WESLEY 0.14%  (48095) ANGO /
GERSUK D JOSEPH EVP - CFO 0.13%  (47275) ABMC / ANGO /
LaPorte Steve 0.12%  (42177) ANGO /
Frost Mark T EVP and CFO 0.11%  (38389) ALOG / ANGO /
Trowbridge Stephen A SVP and General Counsel 0.09%  (33172) ANGO /
Kapusta Matthew C SVP, Business Development 0.08%  (30062) ANGO / QURE /
PANZER ALAN SVP, GM - Vascular 0.08%  (27500) ANGO /
Bourne George W. IV SVP and CT&OO 0.07%  (23613) ANGO /
SOTO JOHN SVP - Global Franchise Leader 0.06%  (22452) ANGO /
Greiner Charles R VP - Global Franchise 0.06%  (20910) ANGO /
Richard Stark SVP, GM - Oncology 0.06%  (20754) ANGO /
McGill Stephen SVP, GM - International 0.06%  (20715) ANGO /
Greiner Michael EVP and CFO 0.05%  (16193) ANGO /
Campbell Chad Thomas SVP/GM, Vascular Access 0.04%  (15324) ANGO /
Simpson Robert Arthur SVP/GM, Global Vascular 0.04%  (12683) ANGO /
Etlinger Richard Scott SVP - Global Operations 0.03%  (11957) ANGO /
REED JAN STERN 0.02%  (8292) ANGO / SCL / WBA /
Auen Eileen O'Shea 0.02%  (7976) ANGO / ICFI /

Comments